Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mamdani

Showing results (141-150 of 252) with videos related to

Pageof 26
Sort By:
Journal of the American Geriatrics Society|April 17, 2004
Drug-induced lithium toxicity in the elderly: a population-based studyDavid N Juurlink, Muhammad M Mamdani, Alexander Kopp, et al.
Journal of the American Geriatrics Society|July 12, 2002
Inappropriate prescribing before and after nursing home admissionIrfan A Dhalla, Geoffrey M Anderson, Muhammad M Mamdani, et al.
BMJ (Clinical Research Ed.)|August 20, 2009
Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort studyDavid N Juurlink, Tara Gomes, Lorraine L Lipscombe, et al.
Clinical Pharmacology and Therapeutics|October 25, 2012
A population-based assessment of the drug interaction between levothyroxine and warfarinD Pincus, T Gomes, C Hellings, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 5, 2003
The striking effect of the Heart Outcomes Prevention Evaluation (HOPE) on ramipril prescribing in OntarioKaren Tu, Muhammad M Mamdani, Robert M Jacka, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 24, 2011
Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, CanadaA M Burden, J M Paterson, D H Solomon, et al.
Pharmacoepidemiology and Drug Safety|August 17, 2016
The appropriateness and persistence of testosterone replacement therapy in OntarioDiana Martins, Zhan Yao, Mina Tadrous, et al.
Pediatrics|February 22, 2017
Overdose Risk in Young Children of Women Prescribed OpioidsYaron Finkelstein, Erin M Macdonald, Alejandro Gonzalez, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 17, 2013
Trends in selection and timing of first-line pharmacotherapy in older patients with type 2 diabetes diagnosed between 1994 and 2006P D Foster, M M Mamdani, D N Juurlink, et al.
International Journal of Technology Assessment in Health Care|June 21, 2007
Inequitable distribution of implantable cardioverter defibrillators in OntarioJacob A Udell, David N Juurlink, Alexander Kopp, et al.
Pageof 26

Showing results (141-150 of 252) with videos related to

Sort By:
Pageof 26
Journal of the American Geriatrics Society|April 17, 2004
Drug-induced lithium toxicity in the elderly: a population-based studyDavid N Juurlink, Muhammad M Mamdani, Alexander Kopp, et al.
Journal of the American Geriatrics Society|July 12, 2002
Inappropriate prescribing before and after nursing home admissionIrfan A Dhalla, Geoffrey M Anderson, Muhammad M Mamdani, et al.
BMJ (Clinical Research Ed.)|August 20, 2009
Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort studyDavid N Juurlink, Tara Gomes, Lorraine L Lipscombe, et al.
Clinical Pharmacology and Therapeutics|October 25, 2012
A population-based assessment of the drug interaction between levothyroxine and warfarinD Pincus, T Gomes, C Hellings, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 5, 2003
The striking effect of the Heart Outcomes Prevention Evaluation (HOPE) on ramipril prescribing in OntarioKaren Tu, Muhammad M Mamdani, Robert M Jacka, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 24, 2011
Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, CanadaA M Burden, J M Paterson, D H Solomon, et al.
Pharmacoepidemiology and Drug Safety|August 17, 2016
The appropriateness and persistence of testosterone replacement therapy in OntarioDiana Martins, Zhan Yao, Mina Tadrous, et al.
Pediatrics|February 22, 2017
Overdose Risk in Young Children of Women Prescribed OpioidsYaron Finkelstein, Erin M Macdonald, Alejandro Gonzalez, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 17, 2013
Trends in selection and timing of first-line pharmacotherapy in older patients with type 2 diabetes diagnosed between 1994 and 2006P D Foster, M M Mamdani, D N Juurlink, et al.
International Journal of Technology Assessment in Health Care|June 21, 2007
Inequitable distribution of implantable cardioverter defibrillators in OntarioJacob A Udell, David N Juurlink, Alexander Kopp, et al.
Pageof 26